Clinical Trials · NCT05628558
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Groupe Maladies hémorragiques de Bretagne
- Enrollment
- 800
- Start date
- Jul 2020
- Locations
- 1 site, France
- Primary endpoint
- Influence of different hot spot variants of the F8 gene responsible for hemophilia on the factor VIII pharmacokinetics after desmopressin infusion